1-3 of 3
Christine Pien
Close
Sort by
Journal Articles

Understanding the Role of TRKA Receptor in Acute Myeloid Leukemias: From Proliferation and Pro-Survival Signals to a Novel Therapeutic Approach

Maurizio L Ghisoli, MD, Wendy Fang, MD, Timothy C Graham, BS, Alejandro G Levy, MD, Lizhi Zeng, MD, Sankaranarayanan Kannan, PhD, Riitta M Nolo, PhD, Christine Pien, PhD, Jeffrey L Brown, PhD, Patrick A Zweidler-McKay, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3789.
https://doi.org/10.1182/blood.V112.11.3789.3789
Published: 2008
Journal Articles

Anti-Tumor Activity of IPI-504, a Novel Hsp90 Inhibitor in Multiple Myeloma.

Vito J. Palombella, Ph.D., Emmanuel Normant, Ph.D., Janid Ali, Ph.D., John Barrett, Ph.D., Michael Foley, Ph.D., Yun Gao, Ph.D., Jennie Ge, Ph.D., Asimina T. Georges, Ph.D., David Grayzel, M.D., Louis Grenier, Jebecka Hudak, Roger Pak, Ph.D., Jon Patterson, Christine Pien, Melissa Pink, James Porter, Ph.D., Junbiao Sang, Kerry Spear, Ph.D., Jens Sydor, Ph.D., Jim Wright, Ph.D., Constantine S. Mitsiades, M.D., Kenneth C. Anderson, M.D., Julian Adams, Ph.D., Jeffrey Tong, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4922.
https://doi.org/10.1182/blood.V104.11.4922.4922
Published: 2004
Journal Articles

IPI-504: A Novel hsp90 Inhibitor with In Vitro and In Vivo Anti-Tumor Activity.

Constantine S. Mitsiades, MD, PhD, Nicholas Mitsiades, MD, PhD, Melissa Rooney, Joseph Negri, Corey C. Geer, MSc, Melissa Pink, Christine Pien, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Nikhil C. Munshi, MD, PhD, Paul G. Richardson, MD, John Barrett, PhD, Jeffrey K. Tong, PhD, David Grayzel, Vito Palombella, PhD, Julian Adams, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 2403.
https://doi.org/10.1182/blood.V104.11.2403.2403
Published: 2004